Piermont Capital Management’s Innophos Holdings, Inc. IPHS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-18,508
Closed -$999K 275
2017
Q1
$999K Buy
18,508
+8,832
+91% +$456K 0.24% 155
2016
Q4
$506K Sell
9,676
-50,208
-84% -$2.44M 0.12% 223
2016
Q3
$2.34M Sell
59,884
-200
-0.3% -$8.22K 0.55% 72
2016
Q2
$2.54M Hold
60,084
0.66% 60
2016
Q1
$1.86M Sell
60,084
-1,470
-2% -$40.5K 0.59% 84
2015
Q4
$1.78M Buy
+61,554
New +$2.17M 0.57% 84

Other funds holding IPHS

Piermont Capital Management's IPHS Position: Q2 2017 in Review

Piermont Capital Management sold out of Innophos Holdings, Inc. (IPHS) in Q2 2017, closing a stake of 18,508 shares — an estimated $999K sold.

Piermont Capital Management first reported a position in IPHS in Q4 2015 and held it in 6 quarters. The position peaked at $2.54M in Q2 2016. 177 funds tracked by Wall St. Rank hold IPHS as of Q2 2017.

  • Piermont Capital Management reported no remaining Innophos Holdings, Inc. position as of Q2 2017 after selling out during the quarter.
  • Piermont Capital Management sold 18,508 Innophos Holdings, Inc. shares in Q2 2017, an estimated $999K.
  • Piermont Capital Management first reported a position in Innophos Holdings, Inc. in Q4 2015 and held it in 6 quarters.
  • Piermont Capital Management's Innophos Holdings, Inc. position peaked at $2.54M in Q2 2016.
  • 177 funds tracked by Wall St. Rank held Innophos Holdings, Inc. as of Q2 2017.

Based on Piermont Capital Management's 13F filing for Q2 2017, filed 11 Aug 2017.